Vantictumab (anti-FZD) - Primary antibody, specific to FZD, >95%, high purity, Human IgG2, Antibody of FZD 1;Antibody of FZD 2;Antibody of FZD 5;Antibody of FZD 7;Antibody of FZD 8

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Features and benefits
  • Host species: Human
  • Species reactivity(Reacts with): Human
  • Isotype: Human IgG2
  • Conjugation: Unconjugated
Item Number
Ab175695
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab175695-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$109.90
Ab175695-1mg
1mg
In stock
$519.90
Ab175695-5mg
5mg
In stock
$1,399.90
Ab175695-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,239.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product NameVantictumab (anti-FZD) - Primary antibody, specific to FZD, >95%, high purity, Human IgG2
SynonymsAnti-FZD Reference Antibody | OMP-18R5 | C2orf31 antibody | DKFZP434E2135 antibody | Frizzled 5 seven transmembrane spanning receptor antibody | Frizzled class receptor 5 antibody | Frizzled family receptor 5 antibody | Frizzled homolog 5 antibody | Frizz
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Host speciesHuman
SpecificityFZD
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeANTAGONIST
Mechanism of actionAntibody of FZD 1;Antibody of FZD 2;Antibody of FZD 5;Antibody of FZD 7;Antibody of FZD 8
Product Description

Vantictumab (anti-FZD) is a monoclonal antibody targeting the Wnt signaling pathway with potential antineoplastic activity. Vantictumab (anti-FZD) binds to certain receptors in the Wnt signaling pathway thereby preventing the activation of the Wnt signaling pathway. This results in an inhibition of cancer stem cell (CSC) activity and a subsequent inhibition of cancer cell proliferation.

Product Properties

IsotypeHuman IgG2
Light Chain Typelambda
SDS-PAGE143.16 kDa
Purification MethodProtein A purified
Purity>95%
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS1345009-45-1

Images

Vantictumab (anti-FZD) (Ab175695) - Flow Cytometry
Flow Cytometry analysis of A549 cells labelling FZD (red) with Vantictumab (anti-FZD) (Ab175695). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Vantictumab (anti-FZD) (Ab175695) - SEC
The purity of Vantictumab (anti-FZD) (Ab175695) is more than 95% verified by HPLC.

Associated Targets(Human)

FZD2 Tchem Frizzled-2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FZD7 Tchem Frizzled-7 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FZD8 Tbio Frizzled-8 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FZD1 Tchem Frizzled-1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FZD5 Tbio Frizzled-5 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FZD6 Tbio Frizzled-6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FZD10 Tbio Frizzled-10 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FZD1 Tchem Frizzled-1 (143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FZD2 Tchem Frizzled-2 (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FZD5 Tbio Frizzled-5 (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FZD7 Tchem Frizzled-7 (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FZD8 Tbio Frizzled-8 (3 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
ZJ23F1202208Certificate of AnalysisDec 28, 2023 Ab175695
ZJ23F1202207Certificate of AnalysisDec 28, 2023 Ab175695

Related Documents

References

1. Katoh M, Katoh M.  (2007)  WNT signaling pathway and stem cell signaling network..  Clin Cancer Res,  13  (14): (4042-5).  [PMID:17634527] [10.1021/op500134e]
2. Gurney A, Axelrod F, Bond CJ, Cain J, Chartier C, Donigan L, Fischer M, Chaudhari A, Ji M, Kapoun AM et al..  (2012)  Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors..  Proc Natl Acad Sci USA,  109  (29): (11717-22).  [PMID:22753465] [10.1021/op500134e]

Solution Calculators